1001 - Document - Cover link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization, Business Operations and Liquidity link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Digital Assets link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Reverse Recapitalization and Sonnet Acquisition link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Contingent Value Rights link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Related Parties link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Stockholders' Equity and Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Reverse Recapitalizatoin and Sonnet Acquisition (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Digital Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Stockholders' Equity and Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Organization, Business Operations and Liquidity (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Summary of Significant Accounting Policies - Computation of Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Summary of Significant Accounting Policies - Summary of Antidilutive Securities Excluded From Computation of Diluted Net Income (Loss) Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Digital Assets - Schedule of Reconciliation of Hype Digital Assets (Details) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Digital Assets - Schedule of Units Held, Cost Basis, and Fair Value of Hype Digital Assets (Details) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value, Assets Measured on Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Schedule of Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Reverse Recapitalization and Sonnet Acquisition (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Reverse Recapitalization and Sonnet Acquisition - Summary of Cost of Acquisition and Allocation to Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Segment Information (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Related Parties (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Stockholders' Equity and Stock-based Compensation (Details Narrative) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Stockholders' Equity and Stock-based Compensation - Schedule of Compensation Expense Allocated (Details) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Stockholders' Equity and Stock-based Compensation - Summary of Restricted Stock Units ("RSUs") Activity (Details) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Stockholders' Equity and Stock-based Compensation - Summary of the Warrant Activity (Details) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Stockholders' Equity and Stock-based Compensation - Schedule of Warrants Outstanding (Details) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:definitionLink link:calculationLink Cover [Abstract] Entity Addresses [Table] Entity Addresses, Address Type [Axis] Address Type [Domain] Business Contact [Member] Entity Addresses [Line Items] Document Type Amendment Flag Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Contact Personnel Name Entity Primary SIC Number Statement of Financial Position [Abstract] Assets [Abstract] Assets Assets, Current [Abstract] Current assets Cash and Cash Equivalent Cash and cash equivalents Prepaid Expense and Other Assets, Current Prepaids and other current assets Receivables, Net, Current Receivable from related party Assets, Current Total current assets Crypto Asset, Fair Value, Noncurrent HYPE digital assets Equity Method Investments Equity method investment Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities Accounts Payable, Current Accounts payable Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Deferred Income Tax Liabilities, Net Deferred tax liability Liabilities Total liabilities Stockholder's Deficit: Stockholders' equity (deficit): Preferred Stock, Value, Issued Series A Preferred stock, $0.01 par value, 100,000,000 shares authorized, 166,173 and 0, shares issued and outstanding as of March 31, 2026, and June 30, 2025, respectively Common stock, $0.01 par value; 1,000 shares authorized; 0 shares issued and outstanding Common stock, $0.01 par value, 2,000,000,000 shares authorized; 127,287,205 shares issued and 124,220,108 shares outstanding (excluding treasury shares of 3,067,097) and 0 shares issued and 0 shares outstanding (excluding treasury shares of 0) as of March 31, 2026, and June 30, 2025, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Accumulated deficit Accumulated deficit Treasury stock, value Treasury stock, at cost; 3,067,097 and 0 shares as of March 31, 2026, and June 30, 2025, respectively Equity, Attributable to Parent Total stockholders' equity (deficit) Beginning balance, value Ending balance, value Liabilities and Equity Total liabilities and stockholders' equity (deficit) Preferred Stock, Par or Stated Value Per Share Series A Preferred stock, par or stated value per share Preferred stock, par or stated value per share Preferred stock, shares authorized Series A Preferred stock, shares authorized Preferred stock, shares authorized Preferred stock, shares outstanding Series A Preferred stock, shares outstanding Preferred stock, shares issued Series A Preferred stock, shares issued Preferred stock, shares issued Common Stock, Par or Stated Value Per Share Common stock, par or stated value per share Common stock, shares authorized Common stock, shares authorized Common stock, shares issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Treasury Stock, Common, Shares Treasury stock, shares Income Statement [Abstract] Revenues [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Operating Income (Loss) [Abstract] Operating income (expense): Crypto Asset, Unrealized Gain, Operating Unrealized gain on HYPE digital assets Unrealized gain on HYPE digital assets Loss On Digital Asset Contribution Commitment Loss on HYPE contribution commitment Loss on HYPE contribution commitment Loss on digital asset contribution commitment. Acquired In Process Resarch And Development Asset IPR&D write-off from Sonnet acquisition Acquired in process resarch and development asset. Selling General And Administrative And Research And Development Expenses Selling, general and administrative and research and development expenses Selling, general and administrative and research and development expenses. Operating Expenses Total operating income (expense) Operating Income (Loss) Operating income (loss) Other Nonoperating Income (Expense) [Abstract] Other income: Other Income Other income Other Nonoperating Income Interest income Other Nonoperating Income (Expense) Total other income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net income (loss) before income taxes Income Tax Expense (Benefit) Provision for income taxes Provision for income taxes Net Income (Loss) Attributable to Parent Net income (loss) Net Loss Net income (loss) Preferred Stock Dividends and Other Adjustments Less: Net income allocated to participating preferred stockholders Less: Net income allocated to preferred stockholders Net Income (Loss) Available to Common Stockholders, Basic Net income (loss) attributable to common stockholders Net income (loss) attributable to common stockholders - basic Earnings Per Share, Basic Net income (loss) per common share - Basic Net Income (Loss) Per Share, Basic Earnings Per Share, Diluted Net income (loss) per common share - diluted Net Income (Loss) Per Share, Diluted Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding - basic Basic weighted-average shares outstanding Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding - diluted Diluted weighted-average shares outstanding Statement of Stockholders' Equity [Abstract] Statement [Table] Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Treasury Common and Preferred Stock [Member] Treasury Stock [Member] Treasury Common and Preferred Stock [Member] Statement [Line Items] Shares, Outstanding Beginning Balance, Shares Ending Balance, Shares Fair value of common stock issued Issuance of shares under Equity Facility, value Stock issued during period, value, new issues Issuance of common stock, value Stock Issued During Period, Shares, New Issues Issuance of shares under Equity Facility, share Stock issued during period, shares, new issues Member cash contribution to Rorschach Member cash contribution to Rorschach Member cash contribution to rorschach. Stock Issued During Period, Value, Acquisitions Equity issued related to acquisition of Sonnet, value Stock Issued During Period, Shares, Acquisitions Equity issued related to acquisition of Sonnet, shares Stock Issued During Period, Value, Issued for Services PIPE financing, net of offering costs, value Stock Issued During Period, Shares, Issued for Services PIPE financing, net of offering costs, shares Acquisition Of Treasury Stock Value Acquisition of treasury stock, value Acquisition of treasury stock value. Acquisition Of Treasury Stock Shares Acquisition of treasury stock, shares Acquisition of treasury stock shares. APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation,Value Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: In Process Resarch And Development Write Off from Sonnet Acquisition IPR&D write-off from Sonnet acquisition In process resarch and development write off from sonnet acquisition. Non Cash Staking Revenue Non cash staking revenue Non cash staking revenue. Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Deferred Income Tax Expense (Benefit) Deferred income tax Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaids and other current assets Increase (Decrease) in Accounts Receivable Receivable from related party Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Other Current Liabilities Other current liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities: Payment for Acquisition, Crypto Asset Purchases of HYPE digital assets Payment For purchase of currency Purchases of USDC PaymentForpurchaseofcurrency Proceeds For purchase of currency Sales of USDC ProceedsForpurchaseofcurrency Proceeds From Asset Acquisition Cash received for the acquisition of Sonnet Proceeds from asset acquisition. Payments to Acquire Equity Method Investments Equity method investment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities: Proceeds from Issuance or Sale of Equity Proceeds from issuance of equity Payments of Stock Issuance Costs Payments for equity issuance costs Payments for Repurchase of Common Stock Repurchases of common stock Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Cash Paid During Period [Abstract] Cash paid during the period for: Cash paid during period. Interest Paid, Excluding Capitalized Interest, Operating Activity Interest Income Taxes Paid, Net Taxes Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Noncash Contribution of Digital Assets Contributions of HYPE digital assets Noncash contribution of digital assets. Equity Issued In Acquisition Equity issued in acquisition of Sonnet Equity issued in acquisition. Deferred purchase price for equity method investment included in other current liabilities Deferred purchase price for equity method investment included in other current liabilities Deferred purchase price for equity method investment included in other current liabilities Transfer of assets in exchange for equity method investment Transfer of assets in exchange for equity method investment Transfer of assets in exchange for equity method investment Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Description of Business Organization, Business Operations and Liquidity Accounting Policies [Abstract] Summary of Significant Accounting Policies Summary of Significant Accounting Policies Digital Assets [Abstract] Digital Assets. Crypto Asset [Text Block] Digital Assets Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Business Combination [Abstract] Business Combination [Text Block] Reverse Recapitalization and Sonnet Acquisition Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Segment Information Contingent Value Rights [Abstract] Contingent value rights. Contingent Value Rights [Text Block] Contingent Value Rights Contingent value rights. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Parties Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity and Stock-based Compensation [Abstract] Stockholders' equity and stock-based compensation. Share-Based Payment Arrangement [Text Block] Stockholders' Equity and Stock-based Compensation Subsequent Events [Abstract] Subsequent Events Subsequent Events Basis of Presentation Basis of Presentation Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Principles of Consolidation Principles of Consolidation Emerging Growth Company Status [Policy Text Block] Emerging Growth Company Status Emerging growth company status. Segment Reporting Segment Reporting Use of Estimates Acquisitions And Valuation Of Intangibles [Policy Text Block] Acquisitions and Valuation of Intangibles Acquisitions and valuation of intangibles. Income Tax, Policy [Policy Text Block] Income Taxes Digital Assets [Policy Text Block] Digital Assets Digital assets. U S Dollar Coin [Policy Text Block] U.S. Dollar Coin U S dollar doin. Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Equity Method Investments [Policy Text Block] Equity Method Investment Revenue from Contract with Customer [Policy Text Block] Staking Revenue Derivatives, Reporting of Derivative Activity [Policy Text Block] Derivatives Treasury Stock [Policy Text Block] Treasury Stock Treasury stock. New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Pending Adoption Earnings Per Share, Policy [Policy Text Block] Net Income (Loss) Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Computation of basic and diluted net loss per share attributable to common shareholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Summary of antidilutive securities excluded from computation of diluted net income (loss) per share Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Summary of Cost of Acquisition and Allocation to Assets Acquired and Liabilities Assumed Crypto Asset, Activity [Table Text Block] Schedule of Reconciliation of Hype Digital Assets Crypto Asset, Holding [Table Text Block] Schedule of Units Held, Cost Basis, and Fair Value of Hype Digital Assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of Fair Value, Assets Measured on Recurring Basis Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Compensation Expense Allocated Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Units ("RSUs") Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of the Warrant Activity Schedule Of Warrants Outstanding [Table Text Block] Schedule of Warrants Outstanding Schedule of warrants outstanding. Organization Consolidation And Presentation Of Financial Statements [Table] Organization consolidation and presentation of financial statements. Business Combination [Axis] Business Combination [Domain] Rorschach Cayman LLC [Member] Rorschach Cayman LLC [Member] Rorschach Cayman LLC. Guidant Bio Therapeutics Inc. [Member] Guidant Bio Therapeutics Inc. Disposal Group Name [Axis] Disposal Group Name [Domain] Asset Purchase Agreement [Member] Asset Purchase Agreement [Member] Asset purchase agreement. Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization consolidation and presentation of financial statements. Ownership Percentage Ownership percentage Ownership percentage. Goodwill Goodwill Disposal Group, Including Discontinued Operation, Consideration cash transactions Disposal Group, Including Discontinued Operation, Deferred Revenue, Current deferred purchase price Business Combination, Voting Equity Interest Acquired, Percentage percentage of common stock interest Business combination, voting equity interest acquired, percentage Disposal Group, Including Discontinued Operation, Operating Expense Services fees expense Product and Service [Axis] Product and Service [Domain] Schedule Of Earnings Per Share Basic And Diluted [Table] Schedule of earnings per share basic and diluted. Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Earnings Per Share Basic And Diluted [Line Items] Earnings per share basic and diluted. Net Income (Loss) Available to Common Stockholders, Diluted Net income (loss) attributable to common stockholders - diluted Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Dilutive effect of service based restricted stock units Federal Deposit Insurance Corporation Insurance Limit Federal deposit insurance corporation insurance limit Federal deposit insurance corporation insurance limit. Business Combination, Recognized Liability Assumed, Deferred Tax Liability Deferred tax expense in connection with the receipt of HYPE Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Statutory tax rate Bonus Depreciation Percentage Bonus depreciation percentage Bonus depreciation percentage. Earnings Per Share [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Advisor Warrants [Member] Advisor Warrants [Member] Advisor warrants. Warrants Issued to Former Sonnet Shareholders [Member] Warrants Issued to Former Sonnet Stockholders [Member] Warrants issued to former Sonnet shareholders. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total Crypto Asset, Activity [Table] Crypto Asset [Axis] Crypto Asset [Domain] Hype [Member] Hype [Member] HYPE Digital Assets [Member] Hype. USDC [Member] USDC USDC. Crypto Asset, Activity [Line Items] Crypto Asset, Fair Value Digital assets beginning balance Digital assets ending balance Fair Value Crypto Asset, Mining Contributions of HYPE digital assets from Rorschach Contributions Crypto Asset, Purchase Purchases Crypto Asset, Sale Sales Crypto Asset, Unrealized Loss, Operating Unrealized gains Crypto Asset, Customer Receipt Receipt of HYPE digital assets from staking activities CryptoAssetCustomerReceiptOther Other receipts of HYPE digital assets CryptoAssetCustomerReceiptOther Crypto Asset, Number of Units Digital assets beginning balance Digital assets ending balance Units Contributions of Digital Assets Number of Units Contributions of HYPE digital assets from Rorschach Contributions Contributions of digital assets number of units. Crypto Asset, Purchase Number of Units Purchases Crypto asset, purchase number of units. CryptoAssetSaleNumberOfUnits Sales CryptoAssetSaleNumberOfUnits Crypto Asset Customer Receipt Number of Units Receipt of HYPE digital assets from staking activities Crypto asset customer receipt number of units. OtherreceiptsofHYPEdigitalassetsNumberOfUnits Other receipts of HYPE digital assets OtherreceiptsofHYPEdigitalassetsNumberOfUnits Crypto Asset, Holding [Table] Crypto Asset, Holding [Line Items] Crypto Asset, Cost Cost Basis Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Money Market Funds [Member] Money market funds Treasury funds [Member] Treasury Funds Treasury funds. Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, Fair Value Disclosure Total assets measured at fair value OCI, Equity Method Investment, after Tax [Abstract] Business Combination [Table] Rorschach Advisors LLC [Member] Rorschach Advisors LLC [Member] Rorschach advisors LLC. Rorschach and Sonnet Merger [Member] Rorschach and Sonnet Merger. Sonnet BioTherapeutics Holdings, Inc. [Member] Sonnet BioTherapeutics Holdings, Inc. [Member] Warrant [Member] Business Combination [Line Items] Number Of Cryptocurrency Token Number of cryptocurrency token Number of cryptocurrency token. Cryptocurrency token value Cryptocurrency token value. Loss on commitment on cryptocurrency token Loss on commitment on cryptocurrency token Business Combination, Separately Recognized Transaction, Acquisition-Related Cost, Incurred Total cost of the acquisition Cash payment to settle outstanding warrants Cash to settle outstanding Sonnet warrants Cash payment to settle outstanding warrants. Business Combination, Transaction Cost, Excluding Separately Recognized Transaction Transaction costs Asset Acquisition [Axis] Asset Acquisition [Domain] Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) [Abstract] Assets Acquired and Liabilities Assumed Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Cash Business Combination, Recognized Asset Acquired, Assembled workforce Assembled workforce Business combination, recognized asset acquired, assembled workforce. Business Combination, Recognized Asset Acquired, In-process Research and Development In-process research and development Business combination, recognized asset acquired, In-process research and development Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Other assets Business Combination, Recognized Liability Assumed, Accounts Payable, Current Accounts payable Business Combination, Recognized Liability Assumed, Other Liability, Current Accrued expenses and other current liabilities Business Combination, Recognized Asset Acquired, Asset Total net assets acquired Asset Acquisition, Consideration Transferred [Abstract] Cost of the Acquisition Business Combination, Consideration Transferred Total consideration paid to Sonnet Number of operating segments Number of operating segments Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Related Party Transaction [Table] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Advisor [Member] Advisor. Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Advisor Rights and Strategic Advisor Agreement [Member] Advisor Rights and Strategic Advisor Agreement [Member] Advisor rights and strategic advisor agreement. Related Party Transaction [Axis] Related Party Transaction [Domain] Additional Paid in Capital and Acquisition of Sonnet [Member] Additional Paid in Capital and Acquisition of Sonnet [Member] Additional paid in capital and acquisition of Sonnet. Business Combination, Pro Forma Information, Nonrecurring Adjustment [Axis] Business Combination, Pro Forma Information, Nonrecurring Adjustment [Domain] Business Combination, Pro Forma Information, Nonrecurring Adjustment, Acquisition-Related Cost [Member] Cost of Asset Acquisition [Member] Agreement [Axis] Agreement. Agreement [Domain] Agreement. Advisor Rights Agreement [Member] Advisor rights agreement. Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] First Advisor Warrant [Member] First advisor warrant. Second Advisor Warrant [Member] Second advisor warrant. Third Advisor Warrant [Member] Third advisor warrant. Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Price Volatility [Member] Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Annual Dividend Rate [Member] Related Party Transaction [Line Items] Business Combination, Contingent Consideration, Liability Liability Warrants and Rights Outstanding Cumulative fair value of warrants Warrants and Rights Outstanding, Measurement Input Risk free rate of return Share Price Stock price Warrants and Rights Outstanding, Term Warrants term Equity Distribution Value of equity distribution Equity distribution. Sale of Stock, Percentage of Ownership after Transaction Sale of stock, percentage of ownership after transaction Percentage Of Common Share Issue Percentage of common share issue Percentage of common share issue. Percentage Of Number Of Share Warrant For Common Share Issue Percentage of number of share warrant for common share issue Percentage of number of share warrant for common share issue. Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Class of warrant or right, number of securities called by each warrant or right Class of Warrant or Right, Exercise Price of Warrants or Rights Class of warrant or right, exercise price of warrants or rights Loss Contingencies [Table] Statement of Financial Position Location, Balance [Axis] Statement of Financial Position Location, Balance [Domain] Other Current Liabilities [Member] Other Current Liabilities [Member] Loss Contingencies [Line Items] Payments For Warrants Payments for warrants Payments for warrants. Fair Value Of Expected Cash Settlement Amount Fair value of expected cash settlement amount Fair value of expected cash settlement amount. Payment Related To Exercises Of Cash Settlement Option Payment related to exercises of cash settlement option Payment related to exercises of cash settlement option. Remaining Expected Cash Settlement Amount Remaining expected cash settlement amount Remaining expected cash settlement amount. Stockholders' Equity and Stock-based Compensation [Table] Stockholders' equity and stock-based compensation. Series A Preferred Stock [Member] Series A Preferred Stock [Member] us-gaap_AwardTypeAxis us-gaap_AwardTypeAxis us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain Restricted Stock Units (RSUs) [Member] Restricted Stock Units ("RSUs") Plan Name [Axis] Plan Name [Domain] Equity Incentive Plan 2025 [Member] Equity Incentive Plan 2025 Member Chardan Capital Markets LLC [Member] Chardan Capital Markets LLC [Member] Chardan Capital Markets LLC Member Vesting [Axis] Vesting [Domain] Tranche One [Member] Tranche one. Tranche Two [Member] Tranche two. Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] PIPE Financing [Member] PIPE Financing and HYPE Contributions Member PIPE Financing and HYPE Contributions [Member] PIPE Financing and HYPE Contributions. HYPE Contributions [Member] HYPE contributions. Equity Facility [Member] Equity Facility. Stockholders' Equity and Stock-based Compensation [Line Items] Stockholders' equity and stock-based compensation. Preferred Stock, Convertible, Conversion Price Preferred stock, convertible, conversion price Percentage of Beneficially Owner In Excess Of Preferred Stock Percentage of beneficially owner in excess of preferred stock Percentage of beneficially owner in excess of preferred stock. Percentage of Beneficially Owner Of Preferred Stock Holder Percentage of beneficially owner of preferred stock holder Percentage of beneficially owner of preferred stock holder. Common Stock, Capital Shares Reserved for Future Issuance Common stock, capital shares reserved for future issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Price, Granted Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Total unrecognized share-based compensation expense related to unvested RSUs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized share-based compensation expense, recognition period Stock Purchased During Period Shares Stock purchased during period shares Stock purchased during period shares. Line of Credit Facility, Commitment Fee Amount Commitment fees Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Sale of Stock, Number of Shares Issued in Transaction Number of shares issued Sale of common stock, number of shares issued Proceeds from Issuance of Private Placement Cash Contributions Sale of stock commitment amount Sale of stock commitment amount. Conversion of Stock, Shares Converted Conversion of stock, shares converted Shares, Issued Shares, issued Gross proceeds adjusted to additional paid-in capital Gross proceeds adjusted to additional paid-in capital. Cash paid for transaction costs adjusted to additional paid-in capital Cash Paid For Transaction Costs adjusted to additional paid-in capital. Loss on cryptocurrency contribution commitment Loss on cryptocurrency contribution commitment. Share Repurchase Program, Authorized, Amount Share repurchase program, authorized, amount Stock Repurchased During Period, Shares Stock repurchased, shares Stock Repurchased During Period, Value Stock repurchased, value Compensation Related Costs [Abstract] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Selling General and Administrative and Research and Development Expenses [Member] Selling General and Administrative and Research and Development Expenses [Member] Selling general and administrative and research and development expenses. Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Payment Arrangement, Expense Stock-based compensation expense allocated, Total Share-Based Payment Arrangement [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number RSUs, Number of RSUs RSUs undelivered, Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of RSUs, Gramted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of RSUs, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of RSUs, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value RSUs, Weighted Average Grant Date Price RSUs undelivered, Weighted Average Grant Date Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Price, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Price, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Outstanding, Beginning Balance Outstanding, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Issued Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Exercised Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Exercise Price Range [Axis] Exercise Price Range [Domain] Exercise Price One [Member] Exercise Price One. Exercise Price Two [Member] Exercise Price Two. Exercise Price Three [Member] Exercise Price Three. Exercise Price Four [Member] Exercise Price Four. Exercise Price Five [Member] Exercise Price Five. Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Exercise Price Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Outstanding Number of Warrants Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Life in Years Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Consolidated Entities [Axis] Consolidated Entities [Domain] Title and Position [Axis] Title and Position [Domain] Scenario [Axis] Scenario [Domain] Subsequent Event [Line Items] Sale of Stock, Consideration Received on Transaction Net proceeds from sale of common stock Staking Revenue [Member]